1 / 30

Vascular Access Laurie Vinci RN, BSN, CNN September 17, 2011

Vascular Access Laurie Vinci RN, BSN, CNN September 17, 2011. OBJECTIVES. Discuss vascular access options Describe essential components for vascular access assessment Discuss vascular access complications and appropriate interventions. A Patient’s Survival

juniper
Download Presentation

Vascular Access Laurie Vinci RN, BSN, CNN September 17, 2011

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Vascular Access Laurie Vinci RN, BSN, CNN September 17, 2011

  2. OBJECTIVES • Discuss vascular access options • Describe essential components for vascular access assessment • Discuss vascular access complications and appropriate interventions

  3. A Patient’s Survival Depends on Proper Functioning of His Lifeline

  4. Vascular Access Options Arteriovenous Fistula (AVF)- Surgically created connection between an artery and a vein Arteriovenous Graft (AVG)-Synthetic or biologic material implanted subcutaneously and interposed between an artery and a vein Tunneled cuffed catheter Non-tunneled, non-cuffed catheter

  5. A-V Fistula First Breakthrough Initiative (FFBI) Objective: To ensure that people receiving hemodialysis be given the opportunity to be evaluated for an AVF first A functionalfistula is the goal, not the insertion of a fistula with a poor chance at maturing In April 2005, the CMS announced that all dialysis units improve AVF prevalence rates to 66% by end of 2009

  6. Diagnostic Evaluation in in Preparation for an Access • Preferred method: Duplex ultrasound mapping of the upper extremity arteries and veins for all patients • To evaluate central veins: 1) Duplex Ultrasound 2) Venography 3) Magnetic Resonance Angiography (MRA) Should be done on patients with pacemakers or prior catheters NKF KDOQ, 2006, CPG 2

  7. AVF placement in order of priority A wrist (radiocephalic) primary fistula An elbow (brachiocehalic) primary fistula A transposed brachial basilic vein fistula NKF KDOQI, 2006, CPG 2

  8. Advantages of the AVF Lowest rate of thrombosis, require the fewest interventions, longer survival of the access Lower rates of infections than AVG/Catheters Associated with increased survival and lower hospitalization rates Cost of implantation and access maintenance are the lowest long term Outflow veins are autogenous tissue which seals and heals after cannulation. Synthetic grafts only seal by means of a fibrin plug. Can utilize the buttonhole cannulation technique

  9. Disadvantages of the AVF Vein may fail to enlarge or increase wall thickness Long maturation times: weeks to months following creation of AVF before they can be used In some, the vein may be more difficult to cannulate than an AVG Thrombosed AVF may be more difficult in which to restore flow The enlarged vein may be visible and perceived as cosmetically unattractive by some individuals Potential for a “steal syndrome” in patients with compromised peripheral vasculature

  10. Arteriovenous Graft (AVG) • 1) Forearm loop graft, preferable to a straight configuration 2) Upper arm graft 3) Chest wall or “necklace” prosthetic graft or lower extremity fistula or graft (all upper-arm sites should be exhausted)

  11. Advantages of the AVG • Large surface area for cannulation • Technically easier to cannulate than new AVFs • ePTFE grafts: No less than 14 days, ideally 3-6 weeks before cannulation to allow healing of incision and resolution of pain and swelling • Placed in many areas of the body • Variety of shapes to facilitate cannulation • Easier for surgeon to handle, implant, and construct the vascular anastomoses

  12. Disadvantages of the AVG Increased incidence of thrombosis and infection over an AVF Patients have a higher mortality risk than those dialyzed with an AVF Shorter patency rates than an AVF Cannulation sites seal but do not heal Potential for allergic response May cause “steal syndrome” if compromised peripheral vasculature

  13. Assessment of AVF or AVG Assess access vessel: 1) Redness, bruising, hematoma, rash or break in skin, bleeding, exudate, atypical warmth, tenderness/pain, aneurysm or pseudoaneurysm 2) Maturation of the vessel, direction and characteristics of the flow (thrill), auscultate for bruit noting changes in pitch 3) Identify cannulation patterns: rotation of site, presence of buttonholes

  14. Cannulation of AVF and AVG • Confirm direction of blood flow • Select sites away from recent entries • Arterial needle (pull) can be against the flow (retrograde) or with the flow (antegrade) • Venous needle (return) always with the flow and above the arterial needle • Never cannulate into anastomoses, aneurysms, or pseudoaneurysms USEASEPTIC TECHNIQUE

  15. Cannulation AVF and AVG For AVG cannulation: Angle of needle insertion is approximately 45 degrees. First cannulation can be 2 weeks post-op for most grafts using needles of the standard size. For AVF cannulation: Always use a tourniquet. Angle of insertion is approximately 25 degrees. Rotate sites using ROPE LADDER TECHNIQUE or buttonhole cannulation First cannulation of newly matured AVF: if functioning catheter, use a #17 ga. needle for arterial pull and venous return via catheter. Do not “flip” needles. This risks cutting or coring the endothelium of the vessel

  16. Post dialysis AVF/AVG Care Removeneedles at same angle as entry, use needle safety device and discard into sharps container immediately Compress with 2 fingers following completeremoval of the needle to prevent pain and damage to the vessel Optimal to remove one needle at a time. Clamps should be used only if there is no alternative (one site at a time) Do not occlude blood flow in peripheral access, check thrill distal to site of pressure Sites can be dressed with adhesive bandage, guaze, and tape but should never be circumferential nor tight

  17. AVF: INFECTION/INTERVENTIONS Rare, but most often occur at cannulation site Should be treated as a subacute bacterial endocarditis with 6 weeks of antibiotic therapy • Avoid cannulation at the infected site and rest arm • Take blood/wound cultures, then initiate antibiotic therapy with broad spectrum Vancomycin plus an aminoglycoside • Convert to appropriate antibiotic upon culture results • Fistula surgical excision in cases of septic emboli NKF KDOQI, 2006, CPG 5

  18. INFILTRATION: AVF/AVG INTERVENTIONS Pain and swelling (hematoma) at time of cannulation or during the dialysis treatment. On dialysis: low arterial pressure alarmmay indicate arterial needle infiltration, high venous pressure alarm may indicate venous needle infiltration At time of cannulation: remove needle, hold firm pressure until bleeding stops and apply ice. If hematoma is large, ice pack x 15 mins. before trying site again. If venous needle, cannulate above site to avoid feeding into infiltrated area. On dialysis: blood pump off, insert another needle, leave original needle in place unless hematoma enlarges, apply ice to area of infiltration Instruct patient on application of ice intermittently for first 24 hrs., then warm compresses

  19. AVF/AVG STENOSIS Findings indicative of a stenosis: Decreased flows, increased pressures, arm edema Central vessel stenosis: breast, neck, chest, face swelling Appearance of collateral veins AVF does not collapsed with arm elevation Increase in post dialysis bleeding time Difficulty with cannulation Pain Altered characteristic of thrill or bruit Recent pseudoaneurysm formation in AVG

  20. AVF/AVG STENOSIS Underdialysis can be minimized or avoided and the rate of thrombosis reduced via access monitoring and surveillance for vascular access stenosis Interventions Doppler ultrasound or Fistulogram to measure flow and detect stenosis Treatment for hemodynamically significant stenosis (> 50%) is balloon angioplasty. Stenting is sometimes warranted. Follow-up fistulograms may be scheduled. Depending on fistulogram findings, surgical revision may be necessary Venous hypertension: arm elevation above level of heart bnormal physical exam >50% stenosis

  21. Nontunneled, Noncuffed Acute Catheters Can be inserted at the bedside, only in hospitalized patients and used for no more than one week Catheter tips should be in the superior vena cava (SVC); confirmed by CXR or fluoroscopy at time of placement Uncuffed femerol catheter should only be used in bed-bound patients , left in place for no more than 5 days. Highest infection rates NKF KDOQI, 2006,CPG 2

  22. Tunneled, Cuffed Catheters Long term use only in patients: 1) not suitable for AVF or AVG 2) has AVF or AVG planned 3) AVG or AVG waiting to mature 4) waiting for scheduled live donor transplant Preferred site is right internal jugular vein: more direct route to right atrium and lower risk of complication compared to other sites Other options: Rt. External jugular, Lt. internal and external jugular veins, subclavien veins, femerol veins, translumbar and transhepatic access to IVC Should not be placed on same side as maturing AV access

  23. Tunneled, Cuffed Catheters Ultrasound guidance and fluoroscopy used for placement of the catheter Tip of the catheter should be in right mid-atrium Fibrous cuff, about 1 cm from exit site inside tunnel; designed to create a barrier to organism entry and prevent catheter dislodgement

  24. Advantages of Tunneled, Cuffed Catheters Can be inserted into multiple sites relatively easy No maturation time, can be used immediately Cause no changes in cardiac output or myocardial load Provides access for months permitting AVF maturation

  25. Disadvantages of Tunneled Cuffed Catheters High morbidity due to thrombosis and infection Risk of central venous stenosis or occlusion Frequent episodes of occluded catheters due to thrombosis or fibrin sheaths: 1) lytic agent or interventional procedure 2) leads to reduced dialysis adequacy associated with increased morbidity and mortality

  26. Catheter Assessment Absence of: 1) Facial/neck edema, respiratory distress, cardiac arrhythmia 2) Catheter occlusion: inability to withdraw anticoagulant and blood 3) Fibrin sheath with tail blocking the tip holes: ability to push saline but inability to pull 4) Integrity of the catheter, well healed exit site: absence of redness, swelling, discoloration, drainage, bleeding or catheter migration such as a visible cuff

  27. INFILTRATION: AVF/AVG INTERVENTIONS If new access and patient has a catheter access, do not recannulate till swelling has receded If unable to clearly feel or see the vessel, the patient has no catheter and needs dialysis: consider use of short-term catheter REMEMBER TO MAINTAIN VISIBILITY OF THE ACCESS AND CONNECTIONS AT ALL TIMES

  28. CATHETER (CVC) DYSFUNCTION Dysfunction defined as failure to attain and maintain blood flow rate of 300ml/min or greater at a prepump arterial pressure less than -250 mmHg. Signs of CVC dysfunction: low arterial pressure alarms and high venous pressure readings (greater then 250 mmHg) limiting blood flow rates which are not responsive to patient repositioning or catheter flushing, unable to aspirate blood freely Causes: Mechanical (kinks or dislodgement), misplaced sutures, catheter migration, drug precipitation, patient position, catheter integrity, holes/cracks, partial or complete occlusion due to a thrombus or fibrin sheath NKF KDOQI, 2006, CPG 7

  29. CATHETER (CVC) DYSFUNCTION INTERVENTIONS Check for and correct mechanical obstruction such as kinking of catheter, lines or clamp indentation Check for dislodgement evidenced by cuff extrusion Tape in place and report to vascular team Reposition the patient: supine returns the patient to the position when the catheter was inserted, may reposition tip of catheter in Rt. atrium. Central veins also maximally engorged in this position. Change position of the head or have the patient cough

  30. CATHETER (CVC) DYFUNCTION INTERVENTIONS Flush each lumen with 10 ml of normal saline Reverse lines using aseptic technique If flow problem persists, likely thrombus in lumens, on the wall of the vessel or a fibrin sheath. Use thrombolytic agent per MD order May need to change the catheter All catheters “locked” with some anticoagulant to prevent thrombus. Firmly infuse to the volume of the lumens, then quickly reclamp lumen to prevent negative pressure in catheter pulling blood in the side holes.

More Related